Recent And Upcoming FDA Advisory Committee Meetings
Executive Summary
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
You may also be interested in...
OTC Hangover Remedy Safety On Tap For FDA Advisory Committees
CDER schedules an NDAC and DSRMAC joint meeting while also negotiating with industry stakeholders on a potential proposal for a user fee program to support FDA’s work on finalizing monographs or amending monographs with additional ingredients or indications.
Endo’s Opana ER, Generic Oxymorphone Safety Get US FDA Panel Review
Advisory committee to discuss data on abuse of Opana ER and generic oxymorphone extended-release and immediate-release products.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.